Membrane Fluidity as a New Means to Selectively Target Cancer Cells with Fusogenic Lipid Carriers

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Lipid-based carriers, particularly liposomes, are advanced drug delivery systems due to their cell membrane-like composition.
• Current liposome targeting often relies on ligand-receptor interactions for cellular specificity.
• Physicochemical differences in cell membranes between tumor and normal cells are not fully exploited for drug delivery.

Purpose of the Study:

• To develop a novel liposome targeting strategy based on physical compatibility between the liposome and target cell membranes.
• To investigate the role of liposome membrane fluidity in achieving selective cancer cell targeting.
• To explore a cost-effective alternative to covalent grafting for targeted drug delivery.

Main Methods:

• Liposome composition was modulated to alter membrane fluidity.
• Selective targeting was assessed across four cancer cell lines with varying aggressiveness.
• Liposome-cell membrane interaction mechanisms were studied using embedded and encapsulated fluorophores.

Main Results:

• Liposome membrane fluidity modulation enabled selective targeting of cancer cells.
• The interaction mechanism was identified as liposome-cell membrane fusion.
• The approach demonstrated efficacy across diverse cancer cell lines.

Conclusions:

• Liposome membrane fluidity is a critical parameter for designing effective lipid drug carriers.
• Physical compatibility offers a promising, lower-cost alternative to covalent grafting for targeted drug delivery.
• This strategy enhances the potential of liposomes for selective cancer therapy.